which glp-1 medication is best for weight loss Medications: Ozempic the Option You? GLP-1 Medications: Everything You Need

Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026

Encouraged by such results, Saxenda expanded its indication to adolescent patients aged 12-18 with BMI equivalent to 30kg/ adults and weighing 60kg or more in December 2021

Refunds are issued in the event of medical disqualification by a licensed provider

Those studies that did not meet the inclusion criteria were subsequently excluded

But with the swipe of your dashboard, theres alsoPoints